Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Wood

Showing results (1-10 of 200) with videos related to

Pageof 20
Sort By:
British Journal of Clinical Pharmacology|June 25, 2010
Putting cocaine use and cocaine-associated cardiac arrhythmias into epidemiological and clinical perspectiveDavid M Wood, Paul I Dargan
Therapeutic Drug Monitoring|June 8, 2012
Novel psychoactive substances: how to understand the acute toxicity associated with the use of these substancesDavid M Wood, Paul I Dargan
Medicine and Law|February 15, 2019
PATIENTS' RIGHT TO PRIVACY AND PUBLIC INTERESTDavid A Frenkell, David M Wood
British Journal of Clinical Pharmacology|March 8, 2020
The challenge of the novel psychoactive substances: How have we responded and what are the implications of this response?David M Wood, Paul I Dargan
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 9, 2012
Mephedrone (4-methylmethcathinone): what is new in our understanding of its use and toxicityDavid M Wood, Paul I Dargan
The Medical Journal of Australia|August 19, 2008
Comparison of crystalline methamphetamine ("ice") users and other patients with toxicology-related problems presenting to a hospital emergency departmentPaul I Dargan, David M Wood
British Journal of Clinical Pharmacology|October 29, 2020
Regional, national and international datasets: How they improve our understanding of the acute harms associated with prescription medicine misuseDavid M Wood, Paul I Dargan
Clinical Toxicology (Philadelphia, Pa.)|August 14, 2012
Use and acute toxicity associated with the novel psychoactive substances diphenylprolinol (D2PM) and desoxypipradrol (2-DPMP)David M Wood, Paul I Dargan
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology|July 11, 2018
Pesticide-Poisoned Patients: Can They Be Used as Potential Organ Donors?Umesh Mistry, Paul I Dargan, David M Wood
Human Psychopharmacology|March 19, 2015
4-methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (4,4'-DMAR, 4,4'-dimethylaminorex): availability, prevalence of use, desired effects and acute toxicityJames Glanville, Paul I Dargan, David M Wood
Pageof 20

Showing results (1-10 of 200) with videos related to

Sort By:
Pageof 20
British Journal of Clinical Pharmacology|June 25, 2010
Putting cocaine use and cocaine-associated cardiac arrhythmias into epidemiological and clinical perspectiveDavid M Wood, Paul I Dargan
Therapeutic Drug Monitoring|June 8, 2012
Novel psychoactive substances: how to understand the acute toxicity associated with the use of these substancesDavid M Wood, Paul I Dargan
Medicine and Law|February 15, 2019
PATIENTS' RIGHT TO PRIVACY AND PUBLIC INTERESTDavid A Frenkell, David M Wood
British Journal of Clinical Pharmacology|March 8, 2020
The challenge of the novel psychoactive substances: How have we responded and what are the implications of this response?David M Wood, Paul I Dargan
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 9, 2012
Mephedrone (4-methylmethcathinone): what is new in our understanding of its use and toxicityDavid M Wood, Paul I Dargan
The Medical Journal of Australia|August 19, 2008
Comparison of crystalline methamphetamine ("ice") users and other patients with toxicology-related problems presenting to a hospital emergency departmentPaul I Dargan, David M Wood
British Journal of Clinical Pharmacology|October 29, 2020
Regional, national and international datasets: How they improve our understanding of the acute harms associated with prescription medicine misuseDavid M Wood, Paul I Dargan
Clinical Toxicology (Philadelphia, Pa.)|August 14, 2012
Use and acute toxicity associated with the novel psychoactive substances diphenylprolinol (D2PM) and desoxypipradrol (2-DPMP)David M Wood, Paul I Dargan
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology|July 11, 2018
Pesticide-Poisoned Patients: Can They Be Used as Potential Organ Donors?Umesh Mistry, Paul I Dargan, David M Wood
Human Psychopharmacology|March 19, 2015
4-methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (4,4'-DMAR, 4,4'-dimethylaminorex): availability, prevalence of use, desired effects and acute toxicityJames Glanville, Paul I Dargan, David M Wood
Pageof 20